Novartis (NVS) agreed to acquire AveXis (AVXS) for $8.7 billion on Monday. 

"This is squarely in the crosshairs of Biogen (BIIB) which has that great deal with Ionis (IONS) ," said TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer.

Want exclusive investing insight from Jim Cramer? Get 24/7 access to Jim's charitable trust portfolio with a free trial to Action Alerts PLUS!

Watch all of Jim Cramer's full NYSE live shows right here:

More from Video

Commodities Prices Have Crashed -- Time to Worry About Economy In 2019?

Commodities Prices Have Crashed -- Time to Worry About Economy In 2019?

Amgen: Cramer Discusses the AAP Portfolio's New Edition

Amgen: Cramer Discusses the AAP Portfolio's New Edition

Cramer on Constellation Brands, Beer and Pot

Cramer on Constellation Brands, Beer and Pot

60 Seconds: Get Financial Aid to Pay For College

60 Seconds: Get Financial Aid to Pay For College

Fisker CEO: Autonomous Electric Shuttle Will Debut Soon at Major Tech Company

Fisker CEO: Autonomous Electric Shuttle Will Debut Soon at Major Tech Company